NCT03288012 Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics Status UNKNOWN Phase N/A
NCT03285178 A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD) Status COMPLETED Phase PHASE2
NCT03279094 Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease Status RECRUITING Phase PHASE1
NCT03263559 Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507) Status COMPLETED Phase PHASE2
NCT03253211 Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina Status COMPLETED Phase N/A
NCT03249831 A Blood Stem Cell Transplant for Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03247218 A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD Status UNKNOWN Phase PHASE2
NCT03243812 Muscle Function and Its Biological and Physiological Determinants in Sickle Cell Disease Status COMPLETED Phase NA
NCT03240731 HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT03235011 Evaluation of Knowledge Among Adolescents With Sickle Cell Disease. Status COMPLETED Phase N/A
NCT03226691 Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients Status COMPLETED Phase PHASE1
NCT03214354 Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor Status RECRUITING Phase PHASE2
NCT03167450 Examining the Knowledge, Attitudes, and Beliefs of Sickle Cell Disease Patients, Parents of Patients With Sickle Cell Disease, and Providers Towards the Integration of CRISPR in Clinical Care Status COMPLETED Phase N/A